Task order award for "non-clinical safety assessment of spif to support chronic gvhd indication" to IIT research institute
Ended Awarded Last action
- Contract number
- HHSN27100001
- Awardee
-
IIT Research Institute UEI DGBUFQYMKWB5 Part of Illinois Institute Of Technology
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,569,964
Award facts
- Opportunity
-
- CRO Support for NCATS In Vitro and In Vivo Toxicology Studies Pre-Solicitation · N01TR172002 · Posted Apr 7, 2020
- CRO Support for NCATS In Vitro and In Vivo Toxicology Studies Award Notice · Posted May 2, 2016
- Contract value 100% obligated
- $1,569,964.42 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- National Center for Advancing Translational Sciences National Institutes of Health, Department of Health and Human Services
- NAICS code
- 541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 4 offers Multiple Award, Fair Opportunity
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Chicago, IL 60616, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$301,032 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $94,590 | |
| Supplemental Agreement for work within scope | $193,902 | |
| Original award | $1,582,504 |
About this award
IIT Research Institute was awarded a $1.57 million cost-plus-fixed-fee delivery order against the CRO Support for NCATS In Vitro and In Vivo Toxicology Studies master IDIQ contract by the National Institutes of Health's National Center for Advancing Translational Sciences. The task order is for non-clinical safety assessment of SPIF to support the chronic graft-versus-host disease indication. Work will be performed in Chicago, Illinois through November 2020. IIT Research Institute will conduct in vitro and in vivo toxicology studies to evaluate a new investigational drug in support of an investigational new drug application for chronic graft-versus-host disease under the National Center for Advancing Translational Sciences' contract vehicle for contract research organization support services.
Quick answers
Who was awarded contract HHSN27100001?
HHSN27100001 was awarded to IIT Research Institute by National Institute on Drug Abuse (National Institutes of Health) on September 14, 2017.
How much is contract HHSN27100001 worth?
The government has obligated $1,569,964 on HHSN27100001.
Which agency awarded contract HHSN27100001?
National Institute on Drug Abuse (National Institutes of Health) awarded HHSN27100001, with funding from National Center for Advancing Translational Sciences (National Institutes of Health).
Is contract HHSN27100001 an order under another contract?
Yes. HHSN27100001 is a delivery order under HHSN271201700016I, an indefinite delivery contract, on CRO Support for NCATS In Vitro and In Vivo Toxicology Studies.
Was contract HHSN27100001 competed?
The extent of competition for HHSN27100001 was full and open competition. The government received 4 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award